Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens
CRISPR-Cas9 screens are powerful high-throughput tools but can be confounded by nuclease toxicity. Here the authors design a library of variable length gRNAs with thousands of negative controls, including the targeting of ‘safe’ loci to account for on-target site DNA damage toxicity.
Enregistré dans:
Auteurs principaux: | David W. Morgens, Michael Wainberg, Evan A. Boyle, Oana Ursu, Carlos L. Araya, C. Kimberly Tsui, Michael S. Haney, Gaelen T. Hess, Kyuho Han, Edwin E. Jeng, Amy Li, Michael P. Snyder, William J. Greenleaf, Anshul Kundaje, Michael C. Bassik |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/da97c345b50241ee96636d0cb1d3e3fc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements
par: Josh Tycko, et autres
Publié: (2019) -
Roadmap for the use of base editors to decipher drug mechanism of action.
par: Estel Aparicio-Prat, et autres
Publié: (2021) -
Lipid hydrolysis monitoring in wastewater treatment: proof-of-concept for a high throughput vegetable oil emulsion based assay
par: P. Van Gaelen, et autres
Publié: (2021) -
The capital flight quadrilemma: Democratic trade-offs and international investment
par: Michael Bennett
Publié: (2021) -
An engineered transcriptional reporter of protein localization identifies regulators of mitochondrial and ER membrane protein trafficking in high-throughput CRISPRi screens
par: Robert Coukos, et autres
Publié: (2021)